Osiris therapeutics, inc. (OSIR)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenue

142,824

118,514

-

-

-

-

-

-

-

-

Cost of revenue

38,139

32,681

-

-

-

-

-

-

-

-

Revenue

-

-

109,374

79,707

50,835

25,698

7,164

1,263

183

-

Cost of revenue

-

-

30,733

27,020

9,886

6,851

2,420

531

62

-

Gross profit

104,685

85,833

78,641

52,687

40,949

18,847

4,744

-

-

-

Gross profit

-

-

-

-

-

-

-

732

121

-

Operating expenses:
Revenue from collaborative research agreements and royalties

-

-

-

-

-

-

-

-

43,021

-

Revenue from collaborative research agreements and royalties

-

-

-

-

-

-

-

-

-

44,533

Research and development

6,764

4,138

6,324

4,867

3,414

4,330

4,059

4,340

23,501

63,266

Sales and marketing

67,542

61,545

59,057

56,627

36,384

13,810

2,836

-

-

-

General and administrative

19,626

22,139

17,356

9,498

7,563

2,538

2,282

-

6,289

8,312

Shareholder litigation expense

900

-

-

-

-

-

-

-

-

-

Settlement of SEC and shareholder actions

-

-

-

15,212

-

-

-

-

-

-

Fees paid to related parties

-

-

-

-

169

-

2

-

-

-

Share-based payments to related parties

-

-

-

-

403

180

1,918

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

7,008

-

-

Fees paid to related parties

-

-

-

-

-

-

-

87

87

95

Share based payments to related parties

-

-

-

-

-

-

-

-74

-74

-400

Total operating expenses

94,832

87,822

82,737

86,204

47,933

20,858

11,097

11,509

29,951

72,073

Income (loss) from continuing operations

9,853

-1,989

-4,096

-33,517

-6,984

-2,011

-6,353

-10,777

13,191

-27,540

Other income (expense), net

675

-645

417

-1,693

-1,771

414

49

-

-

-

Income (loss) before income taxes from continuing operations

-

-

-3,679

-35,210

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

100

175

-

Other income, net

-

-

-

-

-

-

-

-

-

1,277

Income (loss) before income taxes from continuing operations

10,528

-2,634

-

-

-8,755

-1,597

-6,304

-10,677

13,366

-26,263

Income tax benefit

-26,005

-1,398

70

544

97

-994

-37

-775

241

-2,699

Net income (loss) from continuing operations

36,533

-1,236

-

-

-

-

-

-

-

-

Discontinued operations, net of tax

368

10,021

-

-

-

-

-

-

-

-

Net loss from continuing operations

-

-

-3,749

-35,754

-8,852

-603

-6,267

-9,902

-

-23,564

Loss from discontinued operations, net of income taxes of $516 in 2014, $0 in 2013, and $0 in 2012

-

-

-

-

-1,118

-6,668

-5,318

24,794

-

-

Gain from sale of discontinued operations, net of income taxes of $1,374 in 2013

-

-

-

-

-

49,731

-

-

-

1,084

Gain from sale of discontinued operations, net of income taxes of $4,121 in 2009

-

-

-

-

-

-

-

-

-

37,052

Discontinued operations, net of tax

-

-

-

-

-1,118

43,063

-5,318

24,794

-

38,136

Net income

36,901

8,785

-3,749

-35,754

-9,970

42,460

-11,585

14,892

13,125

14,572

Other comprehensive income:
Unrealized loss on investments

-51

-119

54

-89

-21

-13

-40

23

85

-

Comprehensive income

36,850

8,666

-3,695

-35,843

-9,991

42,447

-11,625

14,915

13,210

-

Net income per share from continuing operations:
Basic and diluted (in shares)

-

-

-

-

34,263

33,307

32,859

32,820

-

-

Basic (in dollars per share)

1.06

-0.04

-0.11

-1.04

-

-

-

-

-

-0.72

Diluted (in dollars per share)

1.06

-0.04

-0.11

-1.04

-

-

-

-

-

-0.72

Net income per share from discontinued operations:
Basic (in dollars per share)

0.01

0.29

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.01

0.29

-

-

-

-

-

-

-

-

Net income per share:
Loss from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

1.16

Basic earnings per share (in dollars per share)

1.07

0.25

-0.11

-1.04

-

-

-

-

0.40

0.45

Loss from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

1.16

Diluted earnings per share (in dollars per share)

1.07

0.25

-0.11

-1.04

-

-

-

-

0.40

0.45

Income (loss) from continuing operations (in dollars per share)

-

-

-

-

-0.26

-0.02

-0.19

-0.30

-

-

Income (loss) from discontinued operations (in dollars per share)

-

-

-

-

-0.03

1.29

-0.16

0.75

-

-

Basic and diluted (in dollars per share)

-

-

-

-

-0.29

1.27

-0.35

0.45

-

-

Weighted average common shares outstanding:
Basic (in shares)

34,526

34,524

34,499

34,422

-

-

-

-

32,784

32,742

Diluted (in shares)

34,573

34,525

34,499

34,422

-

-

-

-

33,097

32,742